Zimmer Biomet Holdings Return on Investment 2006-2019 | ZBH

Current and historical return on investment (ROI) values for Zimmer Biomet Holdings (ZBH) over the last 10 years.
Zimmer Biomet Holdings ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-03-31 $0.08B $19.85B 0.38%
2018-12-31 $0.03B $19.69B 0.16%
2018-09-30 $0.78B $20.82B 3.71%
2018-06-30 $0.77B $21.46B 3.71%
2018-03-31 $0.76B $21.49B 3.71%
2017-12-31 $0.80B $20.65B 3.97%
2017-09-30 $1.02B $19.65B 5.08%
2017-06-30 $1.00B $19.63B 4.94%
2017-03-31 $0.92B $20.47B 4.53%
2016-12-31 $0.82B $20.34B 4.01%
2016-09-30 $0.86B $20.75B 4.13%
2016-06-30 $0.78B $20.08B 3.70%
2016-03-31 $0.44B $20.78B 2.07%
2015-12-31 $0.47B $21.39B 2.32%
2015-09-30 $0.48B $21.68B 2.83%
2015-06-30 $0.61B $21.88B 4.59%
2015-03-31 $1.01B $15.64B 10.14%
2014-12-31 $1.04B $7.98B 12.96%
2014-09-30 $1.16B $7.97B 14.55%
2014-06-30 $1.12B $8.14B 14.08%
2014-03-31 $1.07B $7.92B 13.68%
2013-12-31 $1.07B $7.97B 13.87%
2013-09-30 $0.92B $7.83B 12.12%
2013-06-30 $0.96B $7.58B 12.71%
2013-03-31 $1.05B $7.42B 14.00%
2012-12-31 $1.05B $7.59B 14.06%
2012-09-30 $1.05B $7.57B 14.29%
2012-06-30 $1.07B $7.44B 14.75%
2012-03-31 $1.02B $7.23B 14.29%
2011-12-31 $1.02B $7.09B 14.42%
2011-09-30 $0.95B $7.15B 13.40%
2011-06-30 $0.95B $7.16B 13.57%
2011-03-31 $0.92B $7.01B 13.26%
2010-12-31 $0.92B $6.91B 13.30%
2010-09-30 $1.03B $6.96B 15.06%
2010-06-30 $0.97B $6.87B 14.27%
2010-03-31 $1.03B $6.84B 15.52%
2009-12-31 $1.02B $6.77B 15.68%
2009-09-30 $1.02B $6.58B 16.10%
2009-06-30 $1.03B $6.46B 16.60%
2009-03-31 $1.04B $6.22B 17.22%
2008-12-31 $1.09B $6.11B 18.38%
2008-09-30 $1.20B $5.95B 20.76%
2008-06-30 $1.12B $5.83B 19.82%
2008-03-31 $1.13B $5.82B 20.50%
2007-12-31 $1.13B $5.55B 20.98%
2007-09-30 $1.11B $5.36B 21.25%
2007-06-30 $1.24B $5.38B 24.23%
2007-03-31 $1.20B $5.22B 23.90%
2006-12-31 $1.17B $5.02B 23.43%
2006-09-30 $1.11B $4.91B 22.57%
2006-06-30 $1.10B $4.98B 22.65%
2006-03-31 $1.09B $5.01B 23.01%
2005-12-31 $1.06B $4.76B 22.82%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.226B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.955B 29.11
Medtronic (MDT) Ireland $133.284B 19.04
Stryker (SYK) United States $75.636B 26.99
Boston Scientific (BSX) United States $57.976B 27.79
Baxter (BAX) United States $42.043B 26.50
Smith & Nephew SNATS (SNN) United Kingdom $19.156B 0.00
ResMed (RMD) United States $17.217B 32.90
Canopy Growth (CGC) Canada $13.835B 0.00
Bio-Rad Laboratories (BIO) United States $9.076B 48.12
Aurora Cannabis (ACB) Canada $7.403B 73.00
Insulet (PODD) United States $7.147B 520.74
Hill-Rom Holdings (HRC) United States $6.992B 21.20
Perrigo (PRGO) Ireland $6.052B 10.23
Haemonetics (HAE) United States $6.021B 49.14
GW Pharmaceuticals (GWPH) United Kingdom $5.237B 0.00
ICU Medical (ICUI) United States $5.130B 30.61
Hutchison China MediTech (HCM) China $3.814B 0.00
Neogen (NEOG) United States $3.238B 52.65
Agios Pharmaceuticals (AGIO) United States $2.981B 0.00
NuVasive (NUVA) United States $2.962B 24.19
National Vision Holdings (EYE) United States $2.499B 53.25
Quidel (QDEL) United States $2.360B 24.49
Aphria (APHA) $1.687B 0.00
Cardiovascular Systems (CSII) United States $1.495B 858.80
Phibro Animal Health (PAHC) United States $1.220B 18.28
AtriCure (ATRC) United States $1.159B 0.00
VAREX IMAGING (VREX) United States $1.119B 23.75
Lantheus Holdings (LNTH) United States $1.081B 28.71
OrganiGram Holdings (OGI) Canada $0.993B 0.00
NanoString Technologies (NSTG) United States $0.935B 0.00
PetIQ (PETQ) United States $0.899B 21.84
Quanterix (QTRX) United States $0.846B 0.00
MacroGenics (MGNX) United States $0.812B 0.00
Omeros (OMER) United States $0.794B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.771B 21.61
Cerus (CERS) United States $0.682B 0.00
TG Therapeutics (TGTX) United States $0.638B 0.00
Surmodics (SRDX) United States $0.572B 83.20
OraSure Technologies (OSUR) United States $0.552B 25.40
LeMaitre Vascular (LMAT) United States $0.545B 26.37
Meridian Bioscience (VIVO) United States $0.489B 14.95
Evolus (EOLS) United States $0.371B 0.00
Vapotherm (VAPO) United States $0.364B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.355B 0.00
Zynex (ZYXI) United States $0.355B 36.73
BioLife Solutions (BLFS) United States $0.311B 97.41
Utah Medical Products (UTMD) United States $0.302B 20.93
Bovie Medical (APYX) United States $0.217B 0.00
Cytosorbents (CTSO) United States $0.210B 0.00
Owens & Minor (OMI) United States $0.193B 4.08
Chimerix (CMRX) United States $0.173B 0.00
Rockwell Medical (RMTI) United States $0.172B 0.00
Fonar (FONR) United States $0.140B 7.38
Female Health (VERU) United States $0.134B 0.00
BRAINSWAY LTD (BWAY) Israel $0.111B 0.00
Neurotrope (NTRP) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Surface Oncology (SURF) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 19.21
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Senestech (SNES) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.039B 13.58
Conatus Pharmaceuticals (CNAT) United States $0.031B 0.00
GUARDION HEALTH (GHSI) United States $0.030B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.73